Ignite Creation Date:
2025-12-25 @ 1:02 AM
Ignite Modification Date:
2026-07-06 @ 2:05 AM
Study NCT ID:
NCT05904093
Status:
RECRUITING
Last Update Posted:
2025-09-15
First Post:
2023-06-13
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Organization:
Organization Data
Organization:
Class:
NIH
Study ID:
10001619
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NIH
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None